Brain Neoplasms  >>  Torisel (temsirolimus)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Torisel (temsirolimus) / Pfizer
NCT00003712: CCI-779 in Treating Patients With Advanced Solid Tumors

Completed
1
15
US
temsirolimus
The University of Texas Health Science Center at San Antonio, National Cancer Institute (NCI), University of Texas, Wyeth is now a wholly owned subsidiary of Pfizer
Brain and Central Nervous System Tumors, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
06/02
06/02
NCT00949026: Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral Microdialysis

Withdrawn
1
0
US
Temsirolimus (Torisel), Torisel
Emory University, Wyeth is now a wholly owned subsidiary of Pfizer
Brain Neoplasms
05/10
05/10

Download Options